Stephen C. Yang

Stephen C. Yang

Auto-generated profile, based on publicly available information

Stephen C. Yang


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2023 in Science Immunology
Verified
Journal Article
Closed access
ADArbor G. Dykema
Arbor G. Dykema
JZJiajia Zhang
Jiajia Zhang
LCLaurene S. Cheung
Laurene S. Cheung
SCSydney Connor
Sydney Connor
BZBoyang Zhang
Boyang Zhang
KSKellie N. Smith
Kellie N. Smith
Regulatory T cells (Treg) are conventionally viewed as suppressors of endogenous and therapy-induced antitumor immunity; however, their role in modulating responses to immune checkpoint blockade (ICB) is unclear. In this study, we integrated single-cell RNA-seq/T cell receptor sequencing (TCRseq) of >73,000 tumor-infiltrating Treg(TIL-Treg) from anti–PD-1–treated and treatment-naive non–small cell lung cancers (NSCLC) with single-cell analysis of tumor-associated antigen (TAA)–specific Tregderived from a murine tumor model. We identified 10 subsets of human TIL-Treg, most of which have high concordance with murine TIL-Tregsubsets. Only one subset selectively expresses high levels ofTNFRSF4(OX40) andTNFRSF18(GITR), whose engangement by cognate ligand mediated proliferative programs and NF-κB activation, as well as multiple genes involved in Tregsuppression, includingLAG3. Functionally, the OX40hiGITRhisubset is the most highly suppressive ex vivo, and its higher representation among total TIL-Tregcorrelated with resistance to PD-1 blockade. Unexpectedly, in the murine tumor model, we found that virtually all TIL-Treg–expressing T cell receptors that are specific for TAA fully develop a distinct TH1-like signature over a 2-week period after entry into the tumor, down-regulatingFoxP3and up-regulating expression ofTBX21 (Tbet), IFNG, and certain proinflammatory granzymes. Transfer learning of a gene score from the murine TAA-specific TH1-like Tregsubset to the human single-cell dataset revealed a highly analogous subcluster that was enriched in anti–PD-1–responding tumors. These findings demonstrate that TIL-Tregpartition into multiple distinct transcriptionally defined subsets with potentially opposing effects on ICB-induced antitumor immunity and suggest that TAA-specific TIL-Tregmay positively contribute to antitumor responses.

1 January 2014 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
KTKanika Trehan
Kanika Trehan
CKClinton D. Kemp
Clinton D. Kemp
SYStephen C. Yang
Stephen C. Yang

1 February 2012 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
JZJennifer Q. Zhang
Jennifer Q. Zhang
CHCraig M. Hooker
Craig M. Hooker
MBMalcolm V. Brock
Malcolm V. Brock
JSJames Shin
James Shin
SLSue Lee
Sue Lee
SYStephen C. Yang
Stephen C. Yang

1 August 2003
Verified
Journal Article
Closed access
MBMalcolm Brock
Malcolm Brock
MGMingzhou Gou
Mingzhou Gou
YAYoshimitsu Akiyama
Yoshimitsu Akiyama
AMAlison Muller
Alison Muller
TWTsung-Teh Wu
Tsung-Teh Wu
JHJames G Herman
James G Herman

1 March 2012 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
DMDaniela Molena
Daniela Molena
SYStephen C. Yang
Stephen C. Yang

1 February 2016 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
SASaïd C. Azoury
Saïd C. Azoury
JGJoshua C. Grimm
Joshua C. Grimm
STSami H. Tuffaha
Sami H. Tuffaha
JBJustin M. Broyles
Justin M. Broyles
AFAnne C. Fischer
Anne C. Fischer
ATAnthony P. Tufaro
Anthony P. Tufaro
Chest wall reconstruction (CWR) with biologic matrices has gained popularity over the last decade; however, data on this topic remain sparse. The aim of this study is to review the different methods and materials used for CWR while reviewing and highlighting a novel approach using a biologic inlay and synthetic onlay technique for larger, complex high-risk defects. A retrospective review was performed of all patients who underwent full thickness chest wall resection and reconstruction during a 10-year period. Patient characteristics, comorbidities, operative data, as well as postoperative wound complications and outcomes were reviewed. Different reconstructive methods and materials were reviewed and compared. From December 2003 to January 2014, a total of 81 patients underwent CWR. The indications for resection/reconstruction included oncologic in 49 patients (60.5%), desmoids tumors in 10 (12.3%), bronchopleural fistula in 3 (3.7%), infection in 7 (8.6%), and anatomic deformity in 7 (8.6%) patients. Synthetic and/or acellular dermal matrices (ADM) reconstruction was used in 59 patients (10 biologic, 22 synthetic, and 27 biologic ADM inlay/synthetic onlay combination). On average, 2.5, 3.5, and 3.6 ribs were resected in the biologic, synthetic, and combination group, respectively (P = 0.1). A greater number of patients in the combination group had a history of chemotherapy and/or radiation therapy (P = 0.03) than the synthetic or biologic alone groups. Risk analysis demonstrated an association between the number of ribs resected and postoperative chest wall complications. The incidence of chest wall/wound complications in the synthetic, combination, and biologic groups was 31.8%, 22.2%, and 10%, respectively (P = 0.47). In the largest single institution study comparing the use of different reconstructive materials, including ADM in CWR, the authors demonstrate that a biologic inlay/synthetic onlay may be used effectively for high-risk, large complex defects. Early outcomes with this technique are promising. The authors believe this combination highlights benefits from both materials because the ADM facilitates tissue ingrowth and revascularization, whereas the synthetic component provides structural durability. Additional studies with larger sample sizes are necessary to further explore the benefits of the combination technique to determine if outcomes are better than either material alone when used to reconstruct high-risk wounds after larger resections.